That suggests its top-selling insulin products like rapid-acting NovoRapid (insulin aspart), premix NovoMix (insulin aspart/insulin aspart protamine) and long-acting Tresiba (insulin degludec ...
Potential strengths: All the paediatric publications were rated as 1b using the Oxford CEBM grading system and so provide good evidence to support the profile of insulin aspart in terms of more ...
News, August 14, 2006 International Approvals: NovoRapid, TheraCIM, Nexavar The EU has approved an expanded indication for rapid-acting insulin aspart (NovoRapid injection); India has approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback